logo
  

Imperva Inc. (IMPV) Surged To Over A 6-Month High After Q3 Report

Imperva Inc. (IMPV) reported a third quarter non-GAAP loss of $0.10 per share Friday morning, compared to the loss of $0.01 per share in the prior year period. Analysts expected a loss of $0.29 per share. The company expects to report a fourth quarter non-GAAP loss of $0.07 to $0.02 per share and a loss between $0.77 and $0.72 per share for the full year. The consensus estimates are for losses of $0.07 and $0.96 per share.

Imperva gapped open sharply higher Friday and posted gains in early trade, before settling into a range. The stock ended the day higher by 8.49 at $40.97 on strong volume. Imperva jumped to a 6 1/2 month high and re-crossed its 200-day moving average.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT